Online citations, reference lists, and bibliographies.

Glycosaminoglycan-based Biomaterials For Growth Factor And Cytokine Delivery: Making The Right Choices

Daniel Hachim, Thomas E Whittaker, Hyemin Kim, Molly M Stevens
Published 2019 · Chemistry, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Graphical abstract
This paper references
10.1371/journal.pone.0078551
Complexation and Sequestration of BMP-2 from an ECM Mimetic Hyaluronan Gel for Improved Bone Formation
Marta A. Kisiel (2013)
10.1016/j.jconrel.2011.06.042
Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels.
Andrea Zieris (2011)
10.1093/glycob/cwf066
Dermatan sulfate: new functions from an old glycosaminoglycan.
Janet M. Trowbridge (2002)
10.1016/j.biomaterials.2004.09.063
Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair.
Dilek Keskin (2005)
10.1016/j.ijom.2007.05.024
Evaluation of osseointegration of dental implants coated with collagen, chondroitin sulphate and BMP-4: an animal study.
Bernd Stadlinger (2005)
10.1042/bj2850805
Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor.
Hiroko Habuchi (1992)
10.1111/j.1747-0285.2008.00741.x
The structure of glycosaminoglycans and their interactions with proteins.
Neha S. Gandhi (2008)
10.1021/bm5012294
Biohybrid networks of selectively desulfated glycosaminoglycans for tunable growth factor delivery.
Andrea Zieris (2014)
10.2147/IJGM.S5495
Anti-inflammatory effects of hyaluronan in arthritis therapy: Not just for viscosity
Kayo Masuko (2009)
10.1002/mabi.201800283
Novel Surface Coatings Using Oxidized Glycosaminoglycans as Delivery Systems of Bone Morphogenetic Protein 2 (BMP-2) for Bone Regeneration.
Reema Anouz (2018)
10.2147/IJN.S18753
Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds
Qi Tan (2011)
10.1039/c6nr02299e
Injectable shear-thinning nanoengineered hydrogels for stem cell delivery.
Ashish Thakur (2016)
10.1098/rsob.180026
Roles of glycosaminoglycans as regulators of ligand/receptor complexes
Robert G. Smock (2018)
10.1080/10717544.2018.1450910
Application of hyaluronic acid as carriers in drug delivery
Gangliang Huang (2018)
10.1016/j.biomaterials.2017.02.020
A single injection of protein-loaded coacervate-gel significantly improves cardiac function post infarction.
Hassan K. Awada (2017)
10.1016/j.jconrel.2010.11.025
A [polycation:heparin] complex releases growth factors with enhanced bioactivity.
Hunghao Chu (2011)
10.1002/jcb.21570
Chondroitin sulfate prevents platelet derived growth factor-mediated phosphorylation of PDGF-Rbeta in normal human fibroblasts severely impairing mitogenic responses.
Eleni Fthenou (2008)
10.1111/j.1742-7843.2007.00158.x
Chondroitin Sulfate Inhibits the Nuclear Translocation of Nuclear Factor‐κB in Interleukin‐1β‐Stimulated Chondrocytes
Claudia Jomphe (2007)
10.1080/21691401.2018.1452752
ECM based injectable thermo-sensitive hydrogel on the recovery of injured cartilage induced by osteoarthritis
Yitong Li (2018)
10.1016/j.biomaterials.2008.12.057
The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization.
Inbar Freeman (2009)
10.1016/j.jconrel.2006.11.004
Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor.
Jung Seok Lee (2007)
10.1172/JCI4742
Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1.
S F Penc (1999)
10.1089/ten.tea.2011.0192
Sustaining neovascularization of a scaffold through staged release of vascular endothelial growth factor-A and platelet-derived growth factor-BB.
Neil H Davies (2012)
10.3390/ph10020054
The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications
Bethanie I. Ayerst (2017)
10.1006/cyto.1995.0041
Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance.
D Clarke (1995)
10.1039/C9FD00016J
Charge-tuning of glycosaminoglycan-based hydrogels to program cytokine sequestration.
Uwe Freudenberg (2019)
10.1074/jbc.M305530200
Heterogeneity of the Chondroitin Sulfate Portion of Phosphacan/6B4 Proteoglycan Regulates Its Binding Affinity for Pleiotrophin/Heparin Binding Growth-associated Molecule*
Nobuaki Maeda (2003)
10.1590/S0074-02761991000700003
Proteoglycans, glycosaminoglycans and sulfated polysaccharides from connective tissues.
Paulo A. S. Mourão (1991)
10.1002/jbm.a.34128
Heparin-modified dendrimer crosslinked collagen matrices for the delivery of heparin-binding epidermal growth factor.
Marta A. Princz (2012)
10.1083/jcb.122.4.933
Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate
Shigeki Higashiyama (1993)
10.1074/jbc.M412074200
Novel 70-kDa Chondroitin Sulfate/Dermatan Sulfate Hybrid Chains with a Unique Heterogenous Sulfation Pattern from Shark Skin, Which Exhibit Neuritogenic Activity and Binding Activities for Growth Factors and Neurotrophic Factors*
Chilkunda D. Nandini (2005)
10.1039/C5TB00933B
Hydrolysis and Sulfation Pattern Effects on Release of Bioactive Bone Morphogenetic Protein-2 from Heparin-Based Microparticles.
Liane E Tellier (2015)
10.1002/jlb.59.3.435
GM-CSF and IL-3 activities in schistosomal liver granulomas are controlled by stroma-associated heparan sulfate proteoglycans.
Márcio Alvarez-Silva (1996)
10.1074/jbc.M112.398826
Diversification of the Structural Determinants of Fibroblast Growth Factor-Heparin Interactions
Ruoyan Xu (2012)
Nano and Microparticles as Controlled Drug Delivery Devices
Ravi Kumar M.N.V. (2000)
10.1073/pnas.1110121108
Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis
Hunghao Chu (2011)
10.1002/term.1683
Chondrogenic potential of injectable κ-carrageenan hydrogel with encapsulated adipose stem cells for cartilage tissue-engineering applications.
Elena Geta Popa (2015)
10.1002/adhm.201701042
Glycosaminoglycan and Proteoglycan‐Based Biomaterials: Current Trends and Future Perspectives
Jelena Rnjak-Kovacina (2018)
10.1016/j.actbio.2013.07.031
Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications.
Yingkai Liang (2014)
10.1089/ten.TEB.2015.0357
A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.
Aaron Watkins James (2016)
10.1101/glycobiology.3e.017
Proteoglycans and Sulfated Glycosaminoglycans
Ulf Lindahl (2009)
10.1042/bj3010121
Interaction of heparin with synthetic antithrombin III peptide analogues.
Jooeun Bae (1994)
10.1002/adhm.201600797
StarPEG-Heparin Hydrogels to Protect and Sustainably Deliver IL-4.
Lucas Schirmer (2016)
10.1371/journal.pone.0109596
Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4
Katharine J Goodall (2014)
10.1515/polyeng-2015-0379
Photo-crosslinking hyaluronan-heparin hybrid hydrogels for BMP-2 sustained delivery
Tianqi He (2016)
10.1016/j.joca.2008.04.002
Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice.
Giuseppe Maurizio Campo (2008)
10.1016/j.actbio.2005.03.002
Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation.
Danielle S W Benoit (2005)
10.1074/jbc.M608796200
Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1α) Binding to Heparin*
James W. Murphy (2007)
10.1021/am404912c
Biofunctionalization of ulvan scaffolds for bone tissue engineering.
Mamoni Dash (2014)
10.1111/wrr.12319
Coacervate delivery of HB-EGF accelerates healing of type 2 diabetic wounds.
Noah Ray Johnson (2015)
10.1016/S1877-1173(10)93001-9
Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins.
Lijuan Zhang (2010)
10.1074/jbc.M510760200
VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase*
Christopher J. Robinson (2006)
10.1016/j.biomaterials.2012.03.039
Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells.
Silvana Prokoph (2012)
10.1016/S1054-3589(05)53019-9
Immunological activity of chondroitin sulfate.
Toshihiko Toida (2006)
10.1021/bm9008827
Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4).
Vera Hintze (2009)
10.1016/j.biomaterials.2010.07.010
Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.
Jillian E Tengood (2010)
10.1074/jbc.M408129200
Cell-surface Heparan Sulfate Proteoglycans Potentiate Chordin Antagonism of Bone Morphogenetic Protein Signaling and Are Necessary for Cellular Uptake of Chordin*
R. Jasuja (2004)
10.1016/j.biomaterials.2015.08.050
Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair.
William C W Chen (2015)
10.3390/molecules13081671
Fucoidan: Structure and Bioactivity
Bo Li (2008)
10.1039/C9MH00291J
Immunomodulation and cellular response to biomaterials: the overriding role of neutrophils in healing
Biaou O. Ode Boni (2019)
10.1074/jbc.M110.177006
Heparan Sulfate Regulates VEGF165- and VEGF121-mediated Vascular Hyperpermeability*
Ding Xu (2010)
10.15171/bi.2016.08
Applications of electrospinning/electrospraying in drug delivery
Azin Jahangiri (2016)
10.3109/10717544.2010.509357
Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB
Yolanda Parajó (2010)
10.3390/molecules22061025
From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods
Jan-Ytzen van der Meer (2017)
10.1074/jbc.274.34.23916
Stromal Cell-derived Factor-1α Associates with Heparan Sulfates through the First β-Strand of the Chemokine*
Ali Amara (1999)
10.1126/scitranslmed.aai9044
Glycosaminoglycan-based hydrogels capture inflammatory chemokines and rescue defective wound healing in mice
Nadine Lohmann (2017)
10.1152/ajprenal.00579.2015
Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice.
Danielle E. Soranno (2016)
10.1111/j.1524-475X.2009.00466.x
Interactions between extracellular matrix and growth factors in wound healing.
Gregory Scott Schultz (2009)
10.1038/natrevmats.2016.71
Designing hydrogels for controlled drug delivery.
Jianyu Li (2016)
10.1016/j.biomaterials.2005.08.030
Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
Oju Jeon (2006)
10.1021/bi00179a006
Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
Lorna D. Thompson (1994)
10.1016/j.actbio.2014.02.025
Chondroitin-6-sulfate attenuates inflammatory responses in murine macrophages via suppression of NF-κB nuclear translocation.
Guak-Kim Tan (2014)
10.1016/S0168-3659(00)00232-7
Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration.
Yoon Jeong Park (2000)
10.1083/jcb.101.3.1059
Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells
Richard A. Majack (1985)
10.1039/c5sm00131e
The nonlinear viscoelasticity of hyaluronic acid and its role in joint lubrication.
Zhenhuan Zhang (2015)
10.1007/s10719-012-9463-5
Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines
Shuji Mizumoto (2012)
10.1016/j.thromres.2006.10.026
The anti-inflammatory effects of heparin and related compounds.
Edward Young (2008)
10.1016/j.actbio.2018.02.032
Modulation of macrophage phenotype and protein secretion via heparin-IL-4 functionalized supramolecular elastomers.
Valentina Bonito (2018)
10.1248/bpb.27.266
Fucoidan modulates the effect of transforming growth factor (TGF)-beta1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair.
Ronan O’Leary (2004)
10.1093/glycob/4.6.817
Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
M Ishihara (1994)
10.1038/23488
Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme
Erik Forsberg (1999)
10.1111/j.1524-475X.2008.00449.x
FGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferation.
Katherine A. Radek (2009)
10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading.
Pauline B van Wachem (2001)
10.1016/j.jconrel.2015.10.028
Heparin desulfation modulates VEGF release and angiogenesis in diabetic wounds.
Uwe Freudenberg (2015)
10.3892/etm.2012.629
Sodium hyaluronate as a drug-release system for VEGF 165 improves graft revascularization in anterior cruciate ligament reconstruction in a rabbit model
Junming Chen (2012)
10.1016/j.jconrel.2012.11.004
Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing.
Noah Ray Johnson (2013)
10.1088/1741-2560/8/5/056003
Characterization of a chondroitin sulfate hydrogel for nerve root regeneration.
Aaron W. Conovaloff (2011)
10.1021/ACSBIOMATERIALS.5B00077
Coacervate Delivery of Growth Factors Combined with a Degradable Hydrogel Preserves Heart Function after Myocardial Infarction
Noah Ray Johnson (2015)
10.1007/BF01209909
S5.13 Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor
Marco Maccarana (2005)
10.1007/s10965-018-1476-8
Basic fibroblast growth factor released from fucoidan-modified chitosan/alginate scaffolds for promoting fibroblasts migration
Huang-Yu Zeng (2018)
10.1016/j.biomaterials.2017.04.044
Adaptive release of heparin from anticoagulant hydrogels triggered by different blood coagulation factors.
Manfred F Maitz (2017)
10.1016/j.carbpol.2019.01.017
Long-term local PDGF delivery using porous microspheres modified with heparin for tendon healing of rotator cuff tendinitis in a rabbit model.
Seok Ho Kang (2019)
10.1073/pnas.1102962108
Elucidating glycosaminoglycan–protein–protein interactions using carbohydrate microarray and computational approaches
Claude J. Rogers (2011)
10.1016/j.jconrel.2015.03.034
Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.
Hassan K. Awada (2015)
10.3858/emm.2012.44.5.039
Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration
Hee Seok Yang (2012)
10.3390/md9091664
Marine Polysaccharides: A Source of Bioactive Molecules for Cell Therapy and Tissue Engineering
Karim Senni (2011)
10.1182/blood.V96.5.1879.h8001879_1879_1888
Heparin and heparan sulfate bind interleukin-10 and modulate its activity.
Shahram Salek-Ardakani (2000)
10.1016/1357-2725(95)00123-9
Importance of specific amino acids in protein binding sites for heparin and heparan sulfate.
E E Caldwell (1996)
10.3390/microorganisms5030051
The Sea as a Rich Source of Structurally Unique Glycosaminoglycans and Mimetics
Ariana A. Vasconcelos (2017)
10.1242/dev.048926
HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans
Ryo Iwamoto (2010)
10.1021/acs.bioconjchem.5b00397
Chondroitin Sulfate Glycosaminoglycan Hydrogels Create Endogenous Niches for Neural Stem Cells.
Lohitash Karumbaiah (2015)
10.12688/f1000research.6885.1
Viscoelastic Properties of Hyaluronan in Physiological Conditions
Mary K. Cowman (2015)
10.1016/j.actbio.2010.10.009
Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery.
Jeremy J. Lim (2011)
10.1515/acph-2016-0026
A new biocompatible delivery scaffold containing heparin and bone morphogenetic protein 2
Suphannee Thanyaphoo (2016)
10.1093/glycob/8.5.509
Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites.
Saloua Najjam (1998)
10.1002/mabi.201500178
Synergistic Effects of SDF-1α and BMP-2 Delivery from Proteolytically Degradable Hyaluronic Acid Hydrogels for Bone Repair.
Julianne L. Holloway (2015)
10.1074/jbc.M109151200
Heparan Sulfate Proteoglycans Retain Noggin at the Cell Surface
Stephenie Paine-Saunders (2002)
10.1016/j.jmgm.2015.09.003
Identification and characterization of a glycosaminoglycan binding site on interleukin-10 via molecular simulation methods.
Jan-Philip Gehrcke (2015)
10.1016/j.cellimm.2017.10.008
Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
Yan Bai (2018)
10.1016/j.bbapap.2012.07.002
Prediction of heparin binding sites in bone morphogenetic proteins (BMPs).
Neha S. Gandhi (2012)
10.1089/ten.TEA.2009.0390
Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2.
Hee Seok Yang (2010)
10.1074/jbc.M102628200
Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2*
Johan Kreuger (2001)
10.1006/cyto.1996.0142
Human interleukin 4 is a glycosaminoglycan-binding protein.
Hugues Lortat-Jacob (1997)
10.4049/jimmunol.165.10.5671
Characterization of the Heparin-Binding Properties of IL-61
Rosemary S. Mummery (2000)
10.1016/j.biomaterials.2014.05.011
Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2.
Marian H. Hettiaratchi (2014)
10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.0.CO;2-R
Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins.
Ronald E. Hileman (1998)
10.1016/j.biomaterials.2014.02.008
The effect of delivering the chemokine SDF-1α in a matrix-bound manner on myogenesis.
Fabien Dalonneau (2014)
10.1074/jbc.M410412200
Structural and Sequence Motifs in Dermatan Sulfate for Promoting Fibroblast Growth Factor-2 (FGF-2) and FGF-7 Activity*
Kristen R. Taylor (2005)
10.1002/stem.309
Chondroitin sulfates are required for fibroblast growth factor-2-dependent proliferation and maintenance in neural stem cells and for epidermal growth factor-dependent migration of their progeny.
Swetlana Sirko (2010)
10.2147/IJN.S82091
Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles
Bin Wang (2015)
10.1155/2000/31748
Extracellular Matrix and Cytokines: A Functional Unit
Elke Schönherr (2000)
10.1093/glycob/9.7.705
Structural features in heparin that interact with VEGF165 and modulate its biological activity.
Katsuhiro Ono (1999)
10.4052/tigg.14.343
Desulfation of Sulfated Carbohydrates
Ryo Takano (2002)
10.1016/S0003-2697(02)00396-2
Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization.
Ronald Ian William Osmond (2002)
10.1073/pnas.1121318109
A sulfated carbohydrate epitope inhibits axon regeneration after injury
Joshua Brown (2012)
10.1093/glycob/cwg086
Structural investigation of chondroitin/dermatan sulfate oligosaccharides from human skin fibroblast decorin.
Alina D Zamfir (2003)
10.1016/S0369-8114(01)00152-3
Structure and function in extracellular matrices depend on interactions between anionic glycosaminoglycans.
John E. S. Scott (2001)
10.1163/156856209X445285
Heparin-Binding-Affinity-Based Delivery Systems Releasing Nerve Growth Factor Enhance Sciatic Nerve Regeneration
Matthew D Wood (2010)
10.1073/pnas.90.15.7158
Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.
Lynne M. Webb (1993)
10.1177/2041731416677132
In situ formation of poly(vinyl alcohol)–heparin hydrogels for mild encapsulation and prolonged release of basic fibroblast growth factor and vascular endothelial growth factor
Justine J. Roberts (2016)
10.1038/nrm1681
Developmental cell biology: Heparan sulphate proteoglycans: the sweet side of development
Udo Häcker (2005)
10.1242/dev.01522
Functions of heparan sulfate proteoglycans in cell signaling during development
Xinhua Lin (2004)
10.4161/biom.18791
Development of affinity-based delivery of NGF from a chondroitin sulfate biomaterial
Karen Chao Butterfield (2011)
10.4049/jimmunol.180.6.3680
Monocyte Cell Surface Glycosaminoglycans Positively Modulate IL-4-Induced Differentiation toward Dendritic Cells1
Els den Dekker (2008)
10.1038/23481
Heparin is essential for the storage of specific granule proteases in mast cells
Donald E. Humphries (1999)
10.1016/j.actbio.2016.05.036
Heparinized collagen sutures for sustained delivery of PDGF-BB: Delivery profile and effects on tendon-derived cells In-Vitro.
Mousa Younesi (2016)
10.1016/j.carbpol.2015.07.063
Chondroitin sulfate-based nanocarriers for drug/gene delivery.
Lili Zhao (2015)
10.1016/j.expneurol.2015.08.015
Sugar-dependent modulation of neuronal development, regeneration, and plasticity by chondroitin sulfate proteoglycans
Gregory M. Miller (2015)
10.1016/j.jconrel.2011.06.027
Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels.
Oju Jeon (2011)
10.1074/jbc.R111.298430
Chondroitin Sulfate “Wobble Motifs” Modulate Maintenance and Differentiation of Neural Stem Cells and Their Progeny*
Anurag Purushothaman (2011)
10.1016/j.biomaterials.2018.07.056
In situ-forming, cell-instructive hydrogels based on glycosaminoglycans with varied sulfation patterns.
Passant Atallah (2018)
10.1093/glycob/cwg046
The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFRalpha1.
Steven M. Rickard (2003)
10.1088/1748-605X/aa5bbc
Electrospun scaffolds functionalized with heparin and vascular endothelial growth factor increase the proliferation of endothelial progenitor cells.
D I Braghirolli (2017)
10.1016/j.sbi.2007.08.015
Chondroitin/dermatan sulfate in the central nervous system.
Kazuyuki Sugahara (2007)
10.1042/BSR20110077
Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides.
Wenjing Zhao (2012)
10.1016/j.chembiol.2006.12.009
Profiling the sulfation specificities of glycosaminoglycan interactions with growth factors and chemotactic proteins using microarrays.
Eric L Shipp (2007)
10.1002/term.2451
A controlled release system for simultaneous delivery of three human perivascular stem cell-derived factors for tissue repair and regeneration.
Nurlan Mansurov (2018)
10.1007/s10856-009-3827-9
Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold
Lei Chen (2010)
10.1016/j.actbio.2013.09.039
Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.
Tobias Miller (2014)
10.1038/nchembio810
Sulfation patterns of glycosaminoglycans encode molecular recognition and activity
Cristal I Gama (2006)
10.1016/0378-5173(92)90133-M
Evaluation of hyaluronan as a vehicle for peptide growth factors
Per T. Prisell (1992)
10.1016/j.joca.2008.06.008
Anti-inflammatory activity of chondroitin sulfate.
Francesca Ronca (1998)
10.1002/adma.201601908
Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials.
Uwe Freudenberg (2016)
10.1074/jbc.M207105200
Specific Molecular Interactions of Oversulfated Chondroitin Sulfate E with Various Heparin-binding Growth Factors
Sarama Sathyaseelan Deepa (2002)
10.3390/gels3040035
Controlled Release of Vascular Endothelial Growth Factor from Heparin-Functionalized Gelatin Type A and Albumin Hydrogels
Christiane Claaßen (2017)
10.1371/journal.pone.0054622
The Effect of Heparin-VEGF Multilayer on the Biocompatibility of Decellularized Aortic Valve with Platelet and Endothelial Progenitor Cells
Xiaofeng Ye (2013)
10.1093/glycob/10.1.21
Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1alpha.
Elisabeth Mbemba (2000)
10.1074/jbc.M002538200
Neuronal Cell Adhesion, Mediated by the Heparin-binding Neuroregulatory Factor Midkine, Is Specifically Inhibited by Chondroitin Sulfate E
C Ueoka (2000)
10.1007/s10059-012-2294-1
Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ
Deokbum Park (2012)
10.1016/j.ijbiomac.2014.08.029
Keratan sulfate: an up-to-date review.
Vitor H Pomin (2015)
10.1074/jbc.273.43.28116
Dermatan Sulfate Released after Injury Is a Potent Promoter of Fibroblast Growth Factor-2 Function*
S F Penc (1998)
10.1016/j.biotechadv.2017.07.008
Glycosaminoglycans from marine sources as therapeutic agents.
Jesús Valcarcel (2017)
10.1016/j.cyto.2018.04.014
The localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit
Pascale Garnier (2018)
10.1002/jlb.63.3.342
Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix.
Richard Lipscombe (1998)
10.1016/0049-3848(72)90049-7
Heparin derivatives prepared by modification of the uronic acid carboxyl groups
Isidore Danishefsky (1972)
10.3233/BIR-1979-16609
Swelling pressures of proteoglycans at the concentrations found in cartilaginous tissues.
Jill P. G. Urban (1979)
10.1016/J.CARBPOL.2011.05.026
Preparation, structure and BMP-2 controlled release of heparin-conjugated hyaluronan microgels
Jianhao Zhao (2011)
10.1177/0883911511420700
Encapsulation of adipose-derived stem cells and transforming growth factor-β1 in carrageenan-based hydrogels for cartilage tissue engineering
Pedro Rocha (2011)
10.1002/jcp.21557
Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation.
Tatsuya Miyazaki (2008)
10.1016/j.biomaterials.2016.10.019
Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration.
Daniel Hachim (2017)
10.1172/JCI113312
N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation.
Mabel L. Purkerson (1988)
10.1242/jcs.02346
Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing
Yuji Shirakata (2005)
10.1016/j.actbio.2017.09.006
Effects of PDGF-BB delivery from heparinized collagen sutures on the healing of lacerated chicken flexor tendon in vivo.
Mousa Younesi (2017)
10.1242/jcs.058321
The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release
Robin Neely Prince (2010)
10.1016/j.carbpol.2017.02.062
Dual crosslinked chondroitin sulfate injectable hydrogel formed via continuous Diels-Alder (DA) click chemistry for bone repair.
Xiao Bai (2017)
10.1016/j.biomaterials.2019.05.025
Sulfated polysaccharide-based scaffolds for orthopaedic tissue engineering.
Jeremy Nicolas Dinoro (2019)
10.1091/mbc.E10-04-0348
Heparan Sulfate Acts as a Bone Morphogenetic Protein Coreceptor by Facilitating Ligand-induced Receptor Hetero-oligomerization
Wan-Jong Kuo (2010)
10.1021/bi990711d
Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
G S Kuschert (1999)
10.1089/ten.TEA.2013.0523
Adipose-derived stem cells and BMP-2 delivery in chitosan-based 3D constructs to enhance bone regeneration in a rat mandibular defect model.
Jiabing Fan (2014)
10.1016/j.bbrc.2010.09.082
Keratan sulfate suppresses cartilage damage and ameliorates inflammation in an experimental mice arthritis model.
Masatoshi Hayashi (2010)
10.1007/s00109-011-0843-2
Regenerative potential of glycosaminoglycans for skin and bone
Juliane Salbach (2011)
10.1155/2015/537560
Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery
Suniti Misra (2015)
10.1016/b978-0-08-044859-6.x5000-x
Chemistry and biology of heparin and heparan sulfate
Hari G. Garg (2005)
10.1038/srep19871
In vivo vascularization of MSC-loaded porous hydroxyapatite constructs coated with VEGF-functionalized collagen/heparin multilayers
Kai Jin (2016)
10.1002/jor.20875
Enhanced flexor tendon healing through controlled delivery of PDGF-BB.
Stavros Thomopoulos (2009)
10.1016/j.actbio.2019.01.029
Hyaluronan/collagen hydrogels containing sulfated hyaluronan improve wound healing by sustained release of heparin-binding EGF-like growth factor.
Stephan Thoenes (2019)
10.1002/sctm.18-0141
Chondroitin Sulfate Glycosaminoglycan Scaffolds for Cell and Recombinant Protein‐Based Bone Regeneration
Seth Andrews (2019)
10.1016/j.jconrel.2019.05.020
Distinct release strategies are required to modulate macrophage phenotype in young versus aged animals.
Daniel Hachim (2019)
10.1089/ten.TEA.2015.0537
Is Heparin Effective for the Controlled Delivery of High-Dose Bone Morphogenetic Protein-2?
Ri Youn Kim (2016)
10.1016/j.actbio.2017.06.028
Enhanced in vivo retention of low dose BMP-2 via heparin microparticle delivery does not accelerate bone healing in a critically sized femoral defect.
Marian H. Hettiaratchi (2017)
10.2147/IJN.S152246
Sustained-release of FGF-2 from a hybrid hydrogel of heparin-poloxamer and decellular matrix promotes the neuroprotective effects of proteins after spinal injury
He-Lin Xu (2018)
10.3390/md17030183
Biological Activities of Fucoidan and the Factors Mediating Its Therapeutic Effects: A Review of Recent Studies
Yu Wang (2019)
10.1007/s10856-012-4802-4
Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2
Gerjon Hannink (2012)
10.1038/ncomms3168
Bio-responsive polymer hydrogels homeostatically regulate blood coagulation
Manfred F Maitz (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar